300511 雪榕生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)10.1992.336-49.501-11.405-16.833
总资产报酬率 ROA (%)4.7380.799-14.594-4.336-6.831
投入资产回报率 ROIC (%)5.7670.988-17.661-5.035-7.788

边际利润分析
销售毛利率 (%)33.63313.6233.6058.38410.704
营业利润率 (%)25.9162.146-28.385-7.422-16.166
息税前利润/营业总收入 (%)28.1184.820-24.115-4.215-12.923
净利润/营业总收入 (%)25.8721.933-28.505-7.498-16.985

收益指标分析
经营活动净收益/利润总额(%)98.55880.86533.50371.215-1.446
价值变动净收益/利润总额(%)0.0002.6830.1051.381-2.331
营业外收支净额/利润总额(%)-0.143-8.8230.4200.8901.426

偿债能力分析
流动比率 (X)0.6580.3450.2800.3630.919
速动比率 (X)0.3180.1330.1130.1530.577
资产负债率 (%)54.48457.97578.64068.87660.073
带息债务/全部投入资本 (%)39.66240.09666.34356.62647.234
股东权益/带息债务 (%)143.756139.76944.86271.595101.522
股东权益/负债合计 (%)88.28577.20930.96549.04271.264
利息保障倍数 (X)12.5601.692-5.493-1.287-3.717

营运能力分析
应收账款周转天数 (天)5.9566.8065.4004.3864.490
存货周转天数 (天)77.06773.07866.33567.87271.873